Where can I buy HERCEPTIN online?

Pharmacy Remedy provides pharmaceutical sourcing and procurement support offering genuine Roche HERCEPTIN in 150mg and 440mg vials. We provide worldwide shipping with proper cold chain handling. Contact us via WhatsApp at +44 7429 917553 for current pricing and availability.

What is HER2-positive breast cancer?

HER2-positive breast cancer means the cancer cells have high levels of the HER2 protein on their surface, which promotes cancer cell growth. About 20-25% of breast cancers are HER2-positive. While historically aggressive, HER2-positive cancers now have excellent outcomes thanks to targeted therapies like HERCEPTIN.

How long is HERCEPTIN treatment for breast cancer?

For early-stage (adjuvant) breast cancer, HERCEPTIN is typically given for one year (52 weeks) alongside or after chemotherapy. For metastatic breast cancer, treatment continues until disease progression or unacceptable side effects. Your oncologist will determine the optimal duration.

Can HERCEPTIN be used with chemotherapy?

Yes, HERCEPTIN is commonly used in combination with chemotherapy. For early-stage breast cancer, it's often combined with taxanes (paclitaxel or docetaxel) and sometimes anthracyclines. For gastric cancer, it's combined with capecitabine or 5-FU plus cisplatin. The combination is more effective than either treatment alone.

What is the difference between HERCEPTIN 150mg and 440mg?

Both contain the same active ingredient (trastuzumab) at different concentrations. The 150mg vial is typically for smaller patients or those on weekly dosing, while the 440mg vial is often more cost-effective for patients on standard dosing. Your healthcare provider will select the appropriate vial size.

What are the side effects of HERCEPTIN?

Common side effects include infusion reactions (fever, chills), diarrhea, nausea, headache, and fatigue. The most significant concern is cardiotoxicity - HERCEPTIN can affect heart function in some patients. Regular cardiac monitoring with echocardiogram or MUGA scan is required during treatment.

HERCEPTIN

150mg

Oncology Medications

HERCEPTIN150mg

HERCEPTIN (trastuzumab) 150mg is a targeted monoclonal antibody essential for treating HER2-positive breast cancer and gastric cancer, significantly improving survival outcomes.

Generic Name:Trastuzumab

Manufacturer:Roche

Key Benefits

Targeted therapy for HER2-positive cancers
Significantly improves survival in breast cancer
Both adjuvant and metastatic settings
Well-established safety profile over 20+ years
Weekly or 3-weekly dosing options
Authentic Roche product with documentation

Contact Us for Pricing

Get a written quote against a prescription within 24 hours for HERCEPTIN 150mg. Our team is available 24/7.

Direct line: +44 7429 917553

Prescription required

We do not proceed without one

Licensed Türkiye channels

İTS serial-traceable by karekod

Delivered in person

Not shipped by courier

Written reply

Quote within 24 hours

How HERCEPTIN Works

HERCEPTIN works through multiple mechanisms to target HER2-positive cancer cells:

1. **Receptor Blockade:** HERCEPTIN binds to the extracellular domain of HER2, preventing receptor dimerization and downstream signaling that promotes cancer cell proliferation and survival.

2. **Antibody-Dependent Cellular Cytotoxicity (ADCC):** The Fc portion of HERCEPTIN recruits natural killer (NK) cells and other immune effector cells to destroy HER2-positive cancer cells.

3. **Inhibition of HER2 Shedding:** HERCEPTIN prevents the cleavage of the HER2 extracellular domain, maintaining the full receptor on the cell surface where it can be targeted.

4. **Anti-Angiogenic Effects:** HERCEPTIN may inhibit angiogenesis (new blood vessel formation) that tumors need to grow.

The combination of direct anti-proliferative effects and immune activation makes HERCEPTIN a powerful targeted therapy for HER2-positive cancers.

About HERCEPTIN 150mg

HERCEPTIN (trastuzumab) 150mg and 440mg by Roche is a humanized monoclonal antibody that specifically targets the HER2 (human epidermal growth factor receptor 2) protein. This groundbreaking targeted therapy has transformed the treatment of HER2-positive breast cancer, which accounts for approximately 20-25% of all breast cancers and was historically associated with poor prognosis. By binding to the HER2 receptor, HERCEPTIN blocks signals that promote cancer cell growth and triggers antibody-dependent cellular cytotoxicity (ADCC), where immune cells are recruited to destroy cancer cells. HERCEPTIN has demonstrated significant improvements in survival when used in both early-stage (adjuvant) and metastatic HER2-positive breast cancer. HERCEPTIN is also approved for HER2-positive metastatic gastric or gastroesophageal junction adenocarcinoma in combination with chemotherapy. Working through licensed Turkish pharmacy channels, we provide authentic Roche HERCEPTIN with complete documentation, proper cold chain handling, and a written quote against a prescription, usually within 24 hours for healthcare providers worldwide.

Common Uses

HER2-positive early breast cancer (adjuvant)
HER2-positive metastatic breast cancer
HER2-positive gastric/GEJ adenocarcinoma
Combination with chemotherapy
Maintenance therapy

Dosage Information

HERCEPTIN dosing depends on the indication and treatment setting:

Adjuvant Breast Cancer:

Initial dose: 8 mg/kg IV over 90 minutes

Maintenance: 6 mg/kg IV over 30-90 minutes every 3 weeks

Duration: Total of 52 weeks (approximately 1 year)

Metastatic Breast Cancer:

Initial dose: 4 mg/kg IV over 90 minutes

Maintenance: 2 mg/kg IV over 30 minutes weekly, OR

Initial dose: 8 mg/kg IV, then 6 mg/kg every 3 weeks

Metastatic Gastric Cancer (with chemotherapy):

Initial dose: 8 mg/kg IV over 90 minutes

Maintenance: 6 mg/kg IV over 30-90 minutes every 3 weeks

Continue until disease progression

Administer first infusion over 90 minutes with observation. If well tolerated, subsequent infusions may be given over 30 minutes.

Always consult with a qualified healthcare professional for proper dosing. This information is for reference only.

Storage & Handling

Store unopened HERCEPTIN vials under refrigeration at 2°C to 8°C (36°F to 46°F). Do not freeze. Do not shake.

Reconstitution and Dilution:

Reconstitute with provided bacteriostatic water (contains benzyl alcohol)

Solution is stable for 28 days when refrigerated

Dilute in 0.9% Sodium Chloride for infusion

Do not use dextrose solutions

Diluted solution is stable for 24 hours at 2-8°C

For patients with benzyl alcohol hypersensitivity:

Reconstitute with sterile water for injection

Use immediately and discard any unused portion

Protect from light during storage and administration.

We ensure proper cold chain handling during shipping to maintain product integrity.

Full prescribing monograph

A single reference page compiled from the manufacturer's prescribing information and the regulator's public product data. No pricing is published on it.